Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Proviral load in blood was decreased in HTLV-1 infected CD133+ Hu-mice when vCTCF-BS was deleted. by Ancy Joseph (5634794)

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Biological impact of differentially expressed genes by calcitriol in CaSki cervical cancer cells. Diseases and functions obtained from differential expression profiling were analyz... by Euclides Avila (41023)

Subjects:

Semen characteristics in the study population. by Rim Kooli (15426816)

Subjects:

Data. by Rim Kooli (15426816)

Subjects:

Localization of MTT reduction (formazan) in human spermatozoa. by Rim Kooli (15426816)

Subjects:

Line chart of MTT absorbance after PRP supplementation. by Rim Kooli (15426816)

Subjects:

Effect of PRP on spermatozoa ROS production as assessed by the NBT test. by Rim Kooli (15426816)

Subjects:

Effect of PRP on succinate dehydrogenase activity as assessed by the MTT test. by Rim Kooli (15426816)

Subjects:

Line chart of NBT absorbance after PRP supplementation. by Rim Kooli (15426816)

Subjects:

DALY and HLY in Portugal, 1990–2019. The first graph shows a decreasing trend of DALY and the second graph shows an increasing trend of HLY. by Aida Isabel Tavares (12080156)

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

The specific expression of CYP1B1 were explored in different cell types at single-cell level. by Li-Hong Chen (610826)

Subjects:

Signals detection based on sex and subgroup at the SOC level utilizing two disproportionality analysis methods. by Mengsi Peng (12882734)

Subjects:

PVS_volume changes, ΔPVS_volumes, for various radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). by Ruitian Song (11045127)

Subjects:

Results of physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Results of recovery parameters. by Vanessa Wellauer (18408477)

Subjects:

Schematic representation of the experimental protocol over time. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects: